← Back to Search

Enhanced Breastfeeding Support for Increasing Duration

N/A
Waitlist Available
Led By Yukiko Washio, PhD
Research Sponsored by RTI International
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
mothers must be at least 18 years old
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial will test whether adding monthly financial incentives to a standard breastfeeding intervention will improve breastfeeding duration among low-income mothers.

Who is the study for?
The BOOST trial is for new mothers who have started breastfeeding, are at least 18 years old, and understand English at a fifth-grade level. They must be enrolled or eligible for WIC services and plan to stay in the study area for one year postpartum.Check my eligibility
What is being tested?
This trial tests if adding monthly financial rewards to standard WIC support and home visits can extend how long low-income moms breastfeed. The goal is to see if this approach leads to fewer baby health problems and saves on healthcare costs.See study design
What are the potential side effects?
Since this trial involves non-medical interventions like financial incentives and support programs, there are no direct medical side effects. However, participants may experience stress or pressure related to meeting breastfeeding goals.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a mother and I am at least 18 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rate of Breastfeeding
Rate of Pumping
Secondary outcome measures
Infant weight gain
Number of Emergency room and pediatrician visits

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: SC + BFIExperimental Treatment1 Intervention
Participants randomized into SC+BFI will receive the same services as the Standard Care Control (SC) group (standard breastfeeding services from Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) plus monthly home visits that facilitate navigation to as-needed resources and referrals to services that support breastfeeding and problem solving) plus financial incentives contingent on observed breastfeeding.
Group II: SCActive Control1 Intervention
Participants randomized into Standard Care (SC) will receive standard breastfeeding services from Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) plus monthly home visits that facilitate navigation to as-needed resources and referrals to services that support breastfeeding and problem solving.

Find a Location

Who is running the clinical trial?

RTI InternationalLead Sponsor
188 Previous Clinical Trials
875,796 Total Patients Enrolled
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
1,963 Previous Clinical Trials
2,674,573 Total Patients Enrolled
Temple UniversityOTHER
296 Previous Clinical Trials
82,627 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What patient population is eligible for participation in this experiment?

"This trial requires 168 participants that are between 18 and 44 years of age, currently breastfeeding. Furthermore, the mothers must be able to enroll in WIC services or already enrolled, consent voluntarily and meet the minimum legal age requirement of 18."

Answered by AI

Does the experiment accept participants of all ages, including those younger than 65?

"Adhering to the guidelines of this medical trial, only prospective participants between 18 and 44 years old will be considered eligible."

Answered by AI

Are participants still being admitted for this experiment?

"The information on clinicaltrials.gov indicates that the trial is not accepting new participants at this time, as it has been since April 25th 2022 and was first posted June 19 2019. Fortunately, there are 1 other studies actively enrolling patients currently."

Answered by AI
~29 spots leftby Apr 2025